Sumatriptan | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sumatriptan
USP

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Sumatriptan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 26 USDMF, 14 CEP/COS, 4 JDMF, 13 EU WC, 6 KDMF, 20 NDC API, 26 Listed Suppliers, $ API Reference Price

51 API Suppliers
26 USDMF
14 CEP/COS
4 JDMF
13 EU WC
6 KDMF
20 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

396 FDF Dossiers, 100 FDA Orange Book, 212 Europe, 34 Canada, 16 Australia, 19 South Africa, 15 Listed Dossiers

396 FDF Dossiers
100 FDA Orange Book
212 Europe
34 Canada
16 Australia
19 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML), INJECTABLE;SUBCUTANEOUS - EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, SYSTEM;IONTOPHORESIS - EQ 6.5MG BASE/4HR, POWDER;NASAL - EQ 11MG BASE, SPRAY;NASAL - 20MG/SPRAY, SPRAY;NASAL - 5MG/SPRAY, TABLET;ORAL - 500MG;EQ 85MG BASE, TABLET;ORAL - 60MG;EQ 10MG BASE, INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML), INJECTABLE;SUBCUTANEOUS - EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
INJECTABLE;SUBCUTANEOUS - EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
SYSTEM;IONTOPHORESIS - EQ 6.5MG BASE/4HR
POWDER;NASAL - EQ 11MG BASE
SPRAY;NASAL - 20MG/SPRAY
SPRAY;NASAL - 5MG/SPRAY
TABLET;ORAL - 500MG;EQ 85MG BASE
TABLET;ORAL - 60MG;EQ 10MG BASE
INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
INJECTABLE;SUBCUTANEOUS - EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Finar

1 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

1 Parenteral, 1 Topical

1 Parenteral
1 Topical

DIGITAL CONTENT

34 NEWS #PharmaBuzz

34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 178 Finished Drug Prices, 8 Annual Reports

3 US Medicaid Prescriptions
178 Finished Drug Prices
8 Annual Reports

MARKET PLACE

11 APIs, 1 FDF Dossiers

11 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

51 US Patents, 10 Health Canada Patents

51 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 5 Others

3 EDQM
3 USP
5 Others

$ API Ref.Price (USD/KG) : 1,014 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11642154

02 11642201

03 11642256

filter Description Reset all filters

3 All

01 1Sumatriptan (50 mg)

02 1Sumatriptan Succinate (200 mg)

03 1Sumatriptan Succinate Related Impurities (25 mg)

filter CAS Number Reset all filters

3 All

01 1103628-46-2

02 1103628-48-4

03 1N/A

Product Main Page

01

USP

BioAsia

Not Confirmed

USP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sumatriptan (50 mg)

CAS Number : 103628-46-2

Quantity Per Vial :

Price ($) : 305

Catalog Number : 1642154

Current Lot : F0C220

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

BioAsia

Not Confirmed

USP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sumatriptan Succinate (200 mg)

CAS Number : 103628-48-4

Quantity Per Vial :

Price ($) : 305

Catalog Number : 1642201

Current Lot : G0L156

Previous Lot : F1E256 (30-JUN-2013)

NDC Code :

Product Web Link

Digital Content

03

USP

BioAsia

Not Confirmed

USP

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sumatriptan Succinate Related Impurities (25 ...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 935

Catalog Number : 1642256

Current Lot : R031W0

Previous Lot : F0E046 (31-OCT-2016)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!